INVO Bioscience is a Medford-based company that is revolutionizing fertility care by making it more accessible and inclusive to individuals worldwide. Their groundbreaking technology, INVOcell, is the first and only FDA-cleared and CE-marked medical device for intravaginal culture (IVC), allowing the woman's body to act as a natural incubator during fertilization and early embryo development. With exceptional outcomes comparable to IVF and more effective than IUI, INVOcell increases the capacity for clinicians to treat more people, reduces costs, and offers an intimate and connected experience for individuals seeking to realize their dream of parenthood.
INVO Bioscience's mission is to democratize fertility by providing a high-quality fertility solution at an affordable price. They offer full-service partnerships, including resources, training, clinical and lab support, to bring treatment where it is needed. INVOcell is not only a financial and cultural choice but also a personal and emotional one, allowing individuals to be involved right from the very beginning. With a focus on patient-centered care and a commitment to amplifying the infertility market, INVO Bioscience is poised to change the landscape of global infertility.
Generated from the website